Lisses, France

Sebia


USPTO Granted Patents = 16



Trademarks = 2

Forward Citations = 52

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Franck Bellon (7 out of 8 patents)

silverMedal Frédéric Robert (5 out of 5 patents)

bronzeMedal Denis Simonin (4 out of 4 patents)

4.  Georges Nouadje (3 out of 3 patents)

5.  Gérald Deschamps (2 out of 2 patents)

6.  Régis Andre (1 out of 3 patents)

7.  Fréderic Robert (1 out of 1 patent)

8.  Jean-Baptiste Clement (1 out of 1 patent)

9.  Fei Alberto (1 out of 1 patent)

10.  Laurent Vincent (1 out of 1 patent)

11.  Aline Bringard (1 out of 1 patent)

12.  Thierry Ligneel (1 out of 1 patent)

13.  Alberto Fei (1 patent)

14.  Frederic Robert (0 patent)


16 patents:

Company Overview
Sebia is a prominent player in the field of medical diagnostics, specializing in the development and manufacturing of high-performance electrophoresis systems and reagents. The company focuses on providing innovative solutions for the analysis of proteins, enabling healthcare professionals to diagnose and monitor various diseases effectively. With a strong presence in the global market, Sebia is committed to advancing laboratory technologies and enhancing patient care through its cutting-edge products and research initiatives.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Sebia USPTO Patent Assignee Logo
16 Patents

#1 in Lisses

#1,209 in France

#37,788 in the World

Lisses, FR
Lisses, France
Forward Citations = 52

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sebia. Retrieved from https://idiyas.com/company/sebia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…